M. Niens

发表

A factorial experiment for optimizing the PCR conditions in routine genotyping

G. T. te Meerman, A. Diepstra, M. Niens, 2005, Biotechnology and applied biochemistry.

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

G. T. te Meerman, I. Nolte, A. van den Berg, 2008, British journal of haematology.

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.

G. T. te Meerman, I. Nolte, A. van den Berg, 2008, Tissue antigens.

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.

G. T. te Meerman, I. Nolte, M. Platteel, 2007, Blood.

Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell–Directed Type 1 Diabetes Therapies

M. Atkinson, M. Kehry, J. Driver, 2011, Diabetes.

Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma

W. Timens, Y. Bossé, D. Postma, 2016, Allergy.

Serum chemokine levels in Hodgkin lymphoma patients: Highly increased levels of thymus and activation-regulated chemokine and macrophage derived chemokine

A. Diepstra, S. Poppema, L. Visser, 2007 .

The Human Leukocyte Antigen Region and Colorectal Cancer Risk

R. Hofstra, I. Nolte, M. Bruinenberg, 2005, Diseases of the colon and rectum.

Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.

D. Serreze, T. DiLorenzo, J. Kulik, 2016, Methods in molecular biology.

HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

E. Vellenga, G. T. te Meerman, I. Nolte, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

E. Vellenga, I. Nolte, A. Diepstra, 2005, The Lancet.

Prevention of “Humanized” Diabetogenic CD8 T-Cell Responses in HLA-Transgenic NOD Mice by a Multipeptide Coupled-Cell Approach

T. Kay, D. Greiner, D. Serreze, 2011, Diabetes.

Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region

G. T. te Meerman, A. Diepstra, S. Poppema, 2005, European journal of haematology. Supplementum.

The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes

G. M. Taylor, G. T. te Meerman, I. Nolte, 2006, Cancer Epidemiology Biomarkers & Prevention.

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV-positive Hodgkin lymphoma

I. Nolte, M. Platteel, A. Diepstra, 2007 .